خبر استحواذ صندوق أفريقي، على إحدى شركات قطاع الرعاية الصحية، والفرصة واعده.

HIMASH www.youtube.com

Brief Summary

This video discusses an African investment fund's potential acquisition of Mina Pharm, an Egyptian pharmaceutical company. It covers the financial and technical analysis of Mina Pharm's stock, highlighting its potential for growth and profitability. The analysis suggests the stock is undervalued and presents a favorable entry point, but advises caution due to pending regulatory approval and the importance of strong capital management.

  • African investment fund is negotiating to acquire Mina Pharm.
  • Financial analysis indicates the stock is strong and undervalued.
  • Technical analysis suggests a good entry point with specific stop-loss and profit targets.
  • Emphasizes the importance of capital management due to pending regulatory approval.

Introduction

The video introduces news from the stock exchange about an African investment fund looking to acquire a stake in Mina Pharm, a company controlled by the Bardisi family. The fund is in negotiations to acquire shares from Nehali, Wafik, and Shair Bardisi, who collectively own a significant portion (79% and 59%) of Mina Pharm. The goal is to gain complete control over the company, but the deal is pending approval from the Competition Protection Authority. The speaker intends to provide his personal point of view on this news and encourages viewers to research and discuss the topic.

Company Overview and Sector Analysis

Mina Pharm is described as a pharmaceutical company in the health care sector, which is considered promising due to population growth and increasing health needs. The health care sector is already growing and doesn't necessarily need acquisitions to strengthen it. The speaker believes this news will positively impact the stock, but emphasizes the need for financial and technical analysis before making any decisions. He clarifies that his analysis is not an invitation to buy or sell, but rather his personal perspective.

Financial Analysis of Mina Pharm Stock

The financial analysis of Mina Pharm stock reveals that it closed the session at 234 pounds, with fluctuations between 232 and 240 pounds. Over the year, the stock has moved between 145 and 268 pounds, a range of 120 pounds. The market cap is 2 billion 760 million pounds, with a P/E ratio of 20 and a price-to-earnings ratio of 4.6, indicating strong profitability. The company's revenues are 5 billion 665 million pounds, and the basic earnings per share (EPS) is 11 pounds and 68 piasters. Notably, the book value of the share is 389 pounds, significantly higher than its market value of 234 pounds, suggesting the stock is undervalued. The company's profits have increased by 21% compared to the previous year, further supporting its financial strength.

Technical Analysis of Mina Pharm Stock

The technical analysis uses a weekly frame for Mina Pharm stock, highlighting a strong support line at 229 pounds. The stock is currently at 235 pounds, close to this support line. There's an upward trend since 2021, with a double bottom pattern and a confirmed breakout. This suggests a good entry point. A stop loss is recommended at 210 pounds, and a profit target is set at 290 pounds, based on the height of the double bottom pattern.

Conclusion and Recommendations

The video concludes that the African investment fund's interest in acquiring Mina Pharm is supported by the company's strong financial and technical indicators. The stock appears to be in a good entry area, with a stop loss at 210 and a profit target at 290. However, it is crucial to remember that this is not a call to buy or sell, but rather a personal point of view. Strong capital management is essential, limiting investment to 5% of capital, due to the pending regulatory approval, which could potentially reject the deal. If the deal proceeds, increasing investment with every correction is suggested.

Summarize any YouTube video in seconds

Get summaries like this one for any video, in your language, with the free Summ app.

Download on the Apple Store
Get it on Google Play

Transcript

Full transcript of “خبر استحواذ صندوق أفريقي، على إحدى شركات قطاع الرعاية الصحية، والفرصة واعده.”. Click a timestamp to open the video at that moment. Need another video? Use the YouTube transcript generator.

0:00 May the peace, mercy, and blessings of God be upon you. May God keep you all well, healthy, and happy. Today we have exclusive news that appeared in the Stock Exchange newspaper. This news is dated June 25, 29. What is the story behind the news, what is the subject, and what is the exact story? What we will see now is an investment fund. What is its story? An African investment fund. Even Africans have entered the Egyptian Stock Exchange. Guys, we are very important to us. This fund told you that it is negotiating because it wants to acquire the share of the Al-Masha family. Where is it? In Mina Pharm, let's read the news together quickly. It tells you what this man wants to do or what this fund wants to do. This fund wants to acquire the stake owned by the Bardisi family. The Bardisi family is the ones who control Mina Pharm and they have the largest share. That is, it will buy from

0:45 Nehali Bardisi, Wafik Bardisi and Shair Bardisi. They own 79% and 59% of the shares of Mina Pharm. That is, it is their company. So, this man is telling you what he or this fund wants to acquire so that it has complete control over what? On the company, okay, the sources added that this deal is still pending the approval of the Competition Protection Authority. Today, almost all parties have agreed, but they are waiting for this authority to approve and for this story to end. They are asking you, how much time they have ahead of them? They have set a time of two months. Here, how can we enter one by one? I am speaking for myself and this is my personal point of view. No one can touch me. I am telling you, go search and look for it. By the way, I will leave you a link to this news in the

1:30 description below. Go and read the news. Also, chat with your friends and go on social media and search. Tell me what I should do. I will tell you my point of view and God willing, I will do it. I will do it from tomorrow, from tomorrow’s session, God willing. Look, my honorable sir, this Pharm company, so you know, is a company, I mean, a company specialized in the pharmaceutical sector that produces medicines. A company in the health care sector, and this health care sector is a very promising sector. I mean, it is a sector in the first place because of the population increase and these needs. This sector is already growing, meaning it does not need any acquisitions or any strengthening in order to grow. I believe that this will be very useful news for the stock, but how will it benefit us? We must also,

2:17 as we agreed, analyze this stock financially and after that. We will go back and analyze it technically, and after that we will start making the decision that we are going to work on. It is not a decision. Sorry, I am telling you my point of view, and you are the decision maker. Yes, because this is not an invitation to buy or sell. Now we will start talking about the financial analysis of the stock. Let us look, sir. This Mena Pharm stock has closed the session at 234. What is its session today? It is closed at 234. The limit session after which I came up, the news is perfect, but the stock continued to fluctuate in this session only In the session, from 232 it went to 240 pounds. That means it moved from 232. This is the point from which it moved and

3:04 went to how much? From 204 to 240 and we will understand why it went down to 232 when we come to talk about it actually. After that, he told you that the fluctuation during the year of this stock moved from 145 and went to 268, meaning that it moved during this period in the range of 120 pounds, meaning of course, its fluctuations were going up. It was moving in the range of 120 pounds, meaning you can say that we are now in areas almost close to its peak during the year. The market cap of this stock is 2 billion and 760 million pounds. The market value of the stock is 2 billion and 760 million pounds. Its multiple is about 20 times, which is the P2, the ratio of the

3:51 company to earnings. The ratio of the company’s price to earnings is 4.6.6. This is an excellent number, meaning that this company is making very good profits. It can return its profits with its debts in everything in a short time. The revenues of this company within A year that made 5 billion pounds, honestly, that means 5 billion 665 million pounds, a huge number, frankly speaking. The EPS, or basic earnings per share, is 11 pounds and 68 piasters. This of course benefits people who, for example, want returns every year, for example, they bring in income from stocks. This is a number that is also not bad, not useless, but good. I mean, here we are going to come to a very important point, guys, and focus with me very well. The book value, the book value,

4:38 or the book value of the share, the real, actual price of the share is 389 pounds. The real price of the share is 389 pounds. The real price of the share is 389 pounds. This means that this share is cheaper than its actual price by a huge number, because the share’s market value today is 234 pounds, and the book value of the share is 389 pounds. So, what is this number? I think that it is priced much lower than its value. That is, we have the company's profits achieving 21% more profits than the previous year. These are all very good financial indicators that confirm that

5:26 this stock is a very financially strong stock. Come on, let's go to the technical analysis. Let's go. This is the weekly frame for the Menaver stock. As you can see, we have a strong support line. I will explain it to you in the picture now. Yes, the blue line that you are seeing is at 229. We are actually at 235 now. This means that we are about 5 pounds away from the support line. First, we have an upward trend on the weekly basis, starting from approximately 2021. We are now in 2025 and taking this upward trend. We enlarged the screen. We made something called a double bottom pattern and made a breakout for them. We are confirming the breakout now. So, we are at a good entry point. Where will our stop loss be? It won't

6:11 be below 230 or below 229 very soon, so where should we stop loss? At 210, where do you make profits? Now, imagine that you made profits from the rule of these two double rules that you see, these two consecutive ones, their bottom was at 146 and their top was where? At 226, between 146 and 226, how much are you talking about? You are talking about 80 pounds, so I am above this line. I go from 230 to 80 pounds. Where does this 80 pounds take me? You take me to 310. This is the last peak it reached, which was 293. So 310 is still early for it. So our target is at 290. So the

6:57 story and what’s in it will be that we will stop at a loss at 210 and make profits at 290. So the conclusion of this news is that we have an African investment fund that wants to take Mina Pharm Company. We saw its financial analysis because it is strong. We saw the technical analysis and found that we are actually at very good entry areas. As we said, you have the 210 areas below, your stop loss as long as you entered and you take your profits, as we agreed that we take our profits at the highest point, which is 290. Of course, this is not a call to buy or sell. This is just a point of view. The second thing is strong capital management because this news has not been implemented yet. It may not be implemented. It is possible that the authority that they are going to approve of will reject it. This is very likely as well. Yes, yes, it is an essential point that we

7:42 must take into account. We must enter into a strong capital management that does not exceed 5%. Well, if this news is actually implemented and the world goes on, uncle, increase and increase with every correction. With every correction that comes with you, increase, no problem. And the reaction is to stop the loss until God blesses you and you make profits. But, sir, that is all we have today in the Mina Far stock. I hope you liked the episode and enjoyed and benefited. I am Ibrahim Abu Rura and you are on the Himach channel. If you have not subscribed to the channel yet, subscribe now and activate the bell button so that you receive everything new from your channel, the Himach channel. My regards, in God’s care and peace be upon you and God’s mercy and blessings.

Share

More video summaries